Abstract:Angiotensin II (Ang II) is an octapeptide with a central role in cardiovascular homeostasis and actions in several organs including the adrenal gland, kidney, brain, heart, smooth muscle cells and sympathetic nervous system. At these levels it is involved in cellular proliferation and apoptosis, cellular migration, inflammation, synthesis and release of various mediators such as platelet-derived growth factor and endothelin-1) and in the synthesis of extracellular matrix. Traditionally, Ang II was considered a systemic hormone regulating blood pressure, aldosterone release and sodium reabsorption. However, nowadays it is known that this mediator is also formed at the tissue level in the brain, kidney and heart, suggesting local paracrine and autocrine action. At the vascular level, with the exception of renin, all other components of this system are locally produced in vascular adventitia, smooth muscle cells or endothelial cells. In the heart all the components have also been found and their response to humoral, nervous and mechanical stimuli suggests a working local system. Ang II exerts its biological action through two main receptor subtypes: AT-1 and AT-2. The AT-1 receptor is responsible for many of the physiological effects of Ang II in cardiac, vascular, kidney, brain and endocrine cells. Expression of the AT-2 receptor is higher in fetal tissue, especially in mesenchymal tissue (like the tongue, endoderm and diaphragm), decreasing after birth. Its effects are frequently opposite to those mediated bt the AT-1 receptor. Its role in cardiovascular pathophysiology is not yet established. Ang II recruits a complex cascade of intracellular second messengers with different patterns of temporal activation: immediate (in seconds), early (in minutes) and late (in hours). Clinical trials using angiotensin converting enzyme inhibitors (ACEi) and AT-1 receptor antagonists (ARA) have shown improvement in morbidity and mortality in hypertension, congestive heart failure and after myocardial infarction. Although many of the mechanisms underlying these actions are not fully understood, there are no doubts about the beneficial effects of inhibiting this system in the treatment of several cardiovascular diseases.

The Role of Urotensin II in Cardiovascular and Renal Physiology and Diseases

Role of urotensin II in health and disease

Research Progress of Urotensin Ⅱ and Urotensin Ⅱ Receptor

Urotensin II: an Inflammatory Cytokine

Nonhemodynamic Effect of Urotensin-Iiand Its Significance in Some Diseases

Urotensin Ⅱ and diabetes

Urotensin II system in chronic kidney disease

Regulative Effect of Human Urotensin-Ii on Cardiovascular System

[A Vasoactive Peptide: Urotensin II].

Urotensin II Promotes Atherosclerosis in Cholesterol-Fed Rabbits

Effects of urotensin II on isolated rat hearts under normal perfusion and ischemia reperfusion]

Superoxide Mediates Central Cardiovascular Effects of Urotensin Ii in Spontaneously Hypertensive Rats

Urotensin II is an autocrine/paracrine growth factor for aortic adventitia of rat.

Urotensin II Enhances Advanced Aortic Atherosclerosis Formation and Delays Plaque Regression in Hyperlipidemic Rabbits

Urotensin-II Receptor Stimulation of Cardiac L-type Ca2+ Channels Requires the βγ Subunits of Gi/o-protein and Phosphatidylinositol 3-Kinase-dependent Protein Kinase C β1 Isoform

Effects of urotensin II and its specific receptor antagonist urantide on rat vascular smooth muscle cells.

Effects of Exogenous Urotensin Ii on Vascular Remodelling after Balloon Injury

Cardiovascular Effects of Urotensin II in Different Brain Areas

Effect of Chronic Hypoxia on Contents of Urotensin II and Its Functional Receptors in Rat Myocardium

[Renin-angiotensin system and its role in cardiovascular physiopathology and therapy]

Mitogenic Effect of Urotensin Ⅱ on Cells